Oriol de Fabregues-Boixar Nebot I am a neurologist, Head of the Movement Disorder Unit of the Neurology Service. Attention to Parkinson's, dystonia and other neurodegenerative diseases has been one of the challenges that attracted me to Neurology. With this vocation I have attended hundreds of patients with a personalized dedication, introducing new treatments and diagnostic means, and carrying out clinical, epidemiological, therapeutic and basic research work; In short, with an innovative, and enthusiastic attitude. Instituciones de las que forman parte Investigador/a principal Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca Neurología Hospital General Email Oriol de Fabregues-Boixar Nebot Email Instituciones de las que forman parte Investigador/a principal Enfermedades Neurodegenerativas Vall Hebron Institut de Recerca Neurología Hospital General I am a neurologist, Head of the Movement Disorder Unit of the Neurology Service. Attention to Parkinson's, dystonia and other neurodegenerative diseases has been one of the challenges that attracted me to Neurology. With this vocation I have attended hundreds of patients with a personalized dedication, introducing new treatments and diagnostic means, and carrying out clinical, epidemiological, therapeutic and basic research work; In short, with an innovative, and enthusiastic attitude.
I have my degree in Medicine & Surgery at UB and Doctorate in Neuroscience from the UAB, where I am Associate Professor of Medicine at the Faculty of Medicine. I specialized in Neurology, through the MIR system, at the Vall d'Hebron University Hospital. I have been consolidated as a general neurologist at the Hospital de Sabadell Parc Tauli for 10 years. I have specialized in the field of neurodegenerative diseases and movement disorders. Since April 2008 I am the Head of the Movement Disorder Unit of the Hospital. I am a clinical investigator of the VHIR Neurodegenerative Diseases Group. I have been a principal investigator in more than 50 clinical trials and research projects. That have generated numerous publications and scientific communications. I have investigated several clinical aspects of Parkinson's disease and other movement disorders and my main lines of research are the clinical and epidemiology of Parkinson's disease and new treatments for neurodegenerative diseases. I am an expert in botulinum toxin infiltration and have pioneered a complex treatment of Parkinson's disease with a levodopa pump. I have received about twenty awards from scientific societies and I have been distinguished as “Academic corresponent” of the Royal Academy of Medicine of Catalonia. I have been the President of the Catalan Society of Neurology (2012-2014), Member of the Academy of Medical Sciences of Catalonia and the Balearic Islands (2015) and the Patronage of the Interuniversity Institute Foundation-InterAc Salut (2015), Vocal Teaching Director of the Spanish Society of Neurology, (2015-2017) and Vice President of the National Commission of the Specialization of Neurology
Proyectos Malalties neurodegeneratives IP: Miquel Vila Bover Colaboradores: Jorge Hernández Vara, Joan Compte Barrón, Marta Martínez Vicente, Jordi Bove Badell, Eddie Pradas Gracia, Maria Camprodon Gomez, Camille Guillard Sirieix, Marina Lorente Picón, Laura Castillo Ribelles, Oriol de Fabregues-Boixar Nebot, Javier Hoyo Pérez, Ariadna Laguna Tuset, Thais Cuadros Arasa, Jordi Riera Heredia, David Ramos Vicente, Marta Montpeyó Garcia-Moreno, Helena Xicoy Cortada, Alba Nicolau Vera, Marta González Sepúlveda, Joana Margalida Cladera Sastre, Annabelle Parent, Daniela Samaniego Toro Entidad financiadora: Agència Gestió Ajuts Universitaris i de Recerca Financiación: 40000 Referencia: 2021 SGR 00784 Duración: 01/01/2022 - 31/12/2024 Characterization of the CD8 T cell response in Parkinson’s disease for the development of preventive and therapeutic strategies that halt the progression of the disease: SARS-Cov-2-induced long term-hyposmia as a possible prodromal stage IP: Jordi Bove Badell Colaboradores: Miquel Vila Bover, Alejandro Ferré Masó, Oriol de Fabregues-Boixar Nebot, Carles Lorenzo Bosquet, Thais Cuadros Arasa, Antonio Palasi Franco, David Ramos Vicente, Mariona Marchena Herrera Entidad financiadora: Instituto de Salud Carlos III Financiación: 165770 Referencia: PI21/01358 Duración: 01/01/2022 - 31/12/2024 Estudio de la respuesta inmune adaptativa inducida por epítopos derivados de alfa-sinucleína en pacientes con enfermedad de Parkinson: desarrollo de estrategias neuroprotectoras. IP: Jordi Bove Badell Colaboradores: Oriol de Fabregues-Boixar Nebot Entidad financiadora: Instituto de Salud Carlos III Financiación: 141570 Referencia: PI18/01894 Duración: 01/01/2019 - 31/12/2022 La disfunción autofágica/lisosomal en la enfermedad de Parkinson: caracterización y desarrollo de nuevas estrategias traslacionales con el lisosoma como diana terapéutica IP: Marta Martínez Vicente Colaboradores: Jorge Hernández Vara, Oriol de Fabregues-Boixar Nebot, Thais Cuadros Arasa, Jordi Riera Heredia, Marta Montpeyó Garcia-Moreno, Manuel Quintana Luque Entidad financiadora: Instituto de Salud Carlos III Financiación: 99220 Referencia: PI17/00496 Duración: 01/01/2018 - 30/06/2021 Paginación Página actual 1 Página 2 Siguiente página › Última página »
